Cleared Traditional

K162571 - Bioflux Software

K162571 is an FDA 510(k) clearance for Bioflux Software, manufactured by Biotricity, Inc.. The device is a Class 2 Cardiovascular device with product code DSH cleared through the Traditional 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
28d
Days
Class 2
Risk

K162571 is an FDA 510(k) clearance for the Bioflux Software. Classified as Recorder, Magnetic Tape, Medical (product code DSH), Class II - Special Controls.

Submitted by Biotricity, Inc. (Toronto, CA). The FDA issued a Cleared decision on October 13, 2016 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K162571

510(k) Number K162571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2016
Decision Date October 13, 2016
Days to Decision 28 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DSH Device Classification - Class 2, Special Controls

Product Code DSH Recorder, Magnetic Tape, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSH Recorder, Magnetic Tape, Medical

All 134
Devices cleared under the same product code (DSH) and FDA review panel - the closest regulatory comparables to K162571.
Peerbridge Cor(TM) System
K171936 · Peerbridge Health, Inc. · Sep 2017
Stealth System, Stealth Sensor, Stealth Smart Cable, StealthView Software
K162503 · Cardiac Insight, Inc. · Mar 2017
my Patch sl
K163535 · Dms-Service, LLC · Feb 2017
myPatch-s
K160704 · Dms-Service, LLC · Jul 2016
Stealth Monitor, Stealth Docking Cable, Stealth DSD Software Installation Disk, Stealth System
K142468 · Cardiac Insight, Inc. · Jul 2015
ZIO SR ECG Monitoring Service
K143513 · iRhythm Technologies, Inc. · Jun 2015